Fluxapyroxad Patent Landscape Analysis

Developed by BASF and commercialised through the Xemium® brand, fluxapyroxad is a Group 7 SDHI carboxamide fungicide with high intrinsic activity and plant-wide mobility, used on cereals, specialty crops and as a seed treatment.

The report retains 319 patent families across 135 consolidated owner groups. Combination development is the largest and most competitive layer, comprising 206 families and naming 83 partner actives. The upstream estate includes 74 families across compound, crystal form and process and intermediates, with 15 single-active formulation families.

A total of 172 families have a grant or national pending reading, while 24 live families reach their nominal term within five years. One hundred sixty-nine families are held by China-based applicants across 96 China-based owner groups—highlighting both the continuing density of protection and the approaching expiry of selected families.

This 90-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, followed by a complete directory of all 135 owner groups. Detailed patent tables identify holder, parent filing, claimed subject matter, priority, family members, status and term for every retained family.

Not a freedom-to-operate opinion.